Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office
Fish and Richardson
Express Scripts
AstraZeneca
Cantor Fitzgerald
Novartis
Deloitte
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021359

« Back to Dashboard

NDA 021359 describes RECTIV, which is a drug marketed by Forest Labs Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the RECTIV profile page.

The generic ingredient in RECTIV is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 021359
Tradename:RECTIV
Applicant:Forest Labs Inc
Ingredient:nitroglycerin
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021359
Ingredient-typeNitrates
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 021359
Suppliers and Packaging for NDA: 021359
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RECTIV nitroglycerin OINTMENT;INTRA-ANAL 021359 NDA ProStrakan, Inc. 42747-235 42747-235-30 1 TUBE in 1 CARTON (42747-235-30) > 30 g in 1 TUBE
RECTIV nitroglycerin OINTMENT;INTRA-ANAL 021359 NDA ALLERGAN 58914-301 58914-301-85 1 TUBE in 1 CARTON (58914-301-85) > 5 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;INTRA-ANALStrength0.4%
Approval Date:Jun 21, 2011TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Argus Health
Merck
Chubb
Citi
UBS
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot